Skip to main content
Clinical Trials/NCT01731418
NCT01731418
Completed
Not Applicable

Efficacy of Narrative Exposure Therapy (NET) in a Sample of Iranian Women Exposed to Intimate Partner Violence (IPV)

University of Konstanz1 site in 1 country34 target enrollmentNovember 2012

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Mental Disorders
Sponsor
University of Konstanz
Enrollment
34
Locations
1
Primary Endpoint
Perceived Stress Scale-4
Status
Completed
Last Updated
9 years ago

Overview

Brief Summary

The proposed study seeks to investigate to what extent Narrative Exposure Therapy (NET) is an effective treatment for the reduction of symptoms of Post-Traumatic Stress Disorder (PTSD) and depression and for the improvement of daily functioning in Iranian women who have experienced intimate partner violence (IPV). In addition, the study seeks to investigate whether NET therapy could lead to the reduction of Intimate Partner Violence (IPV) within their marriage.

Registry
clinicaltrials.gov
Start Date
November 2012
End Date
December 2015
Last Updated
9 years ago
Study Type
Interventional
Study Design
Parallel
Sex
Female

Investigators

Sponsor
University of Konstanz
Responsible Party
Principal Investigator
Principal Investigator

Tahere Orang

PhD Student

University of Konstanz

Eligibility Criteria

Inclusion Criteria

  • being victims of Intimate Partner Violence and seeking help at target clinics in order to reduce their psychological symptoms, currently living together with their partner/husband, meeting the set cut-off point on the PTSD scale according to DSM-IV.

Exclusion Criteria

  • schizophrenia, epilepsy, mental retardation, drug abuse and mal-nourishment

Outcomes

Primary Outcomes

Perceived Stress Scale-4

Time Frame: At pre-treatment-point, post-treatment-point and 3- and 6-month follow-ups

The Perceived Stress Scale (PSS) would be used to assess the perception of stress over the course of the last month preceding the interview

The Patient Health Questionnaire-9 (PHQ-9)

Time Frame: At pre-treatment-point, post-treatment-point, and 3- and 6-month follow-ups

The Patient Health Questionnaire (PHQ) is a self-administered version of the PRIME-MD diagnostic instrument for common mental disorders. The PHQ-9 is the depression module

The Hopkins Symptom Checklist-25 (HSCL-25)

Time Frame: At pre-treatment-point, post-treatment-point, and 3- and 6-month follow-ups

The Hopkins Symptom Checklist 25 would be used to screen for symptoms of depression and anxiety.

Posttraumatic Diagnostic Scale (PDS/PSS-I).

Time Frame: Symptoms will be assessed at pre-treatment-point and post-treatment-point (up to 6-month follow-ups)

The PDS/PSS-I is a 17-item screening instrument on a 4-point-Likert-scale (0 = not at all to 3 = very much). The PDS aims at assessing all Diagnostic and Statistical Manual (DSM-IV) criteria of a Post Traumatic Stress Disorder (PTSD), and thus it includes information about the nature of the traumatic event and the level of functional interference.

Secondary Outcomes

  • The Work and Social Adjustment Scale (WSAS)(At pre-treatment-point, post-treatment-point and 3- and 6-month follow-ups)
  • Checklist of family violence(At pre-treatment-point, post-treatment-point and 3- and 6-month follow-ups)
  • Composite Abuse Scale (CAS)(At pre-treatment-point, post-treatment-point, and 3- and 6-month follow-ups)
  • The Life Events Checklist(At pre-treatment-point, post-treatment-point and 3- and 6-month follow-ups)

Study Sites (1)

Loading locations...

Similar Trials